E

Edge Therapeutics

10 employees

Edge Therapeutics, a biotechnology company, transforms FDA-approved drugs into therapies that address unmet acute neurological conditions.

Basic info

Sectors

Biotechnology
Health Care
Medical

Date founded

2009

Funding rounds raised

Total raised

$56M

from 7 investors over 7 rounds

E

Edge Therapeutics raised $56M on April 9, 2015

Investors: New Leaf Venture Partners, Sofinnova Ventures, Russia technology fund, Franklin Advisors and Venrock

E

Edge Therapeutics raised $10M on September 8, 2014

Investors: Hercules Capital, Inc.

E

Edge Therapeutics raised $18M on June 4, 2013

Investors: Maxim Group

E

Edge Therapeutics raised undisclosed on May 3, 2010

Investors: New Jersey Economic Development Authority (NJEDA)

FAQ